$562 Million is the total value of Virtus ETF Advisers LLC's 170 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KMI | New | KINDER MORGAN INC DEL | $5,916,000 | – | 272,117 | +100.0% | 1.05% | – |
| SSO | New | PROSHARES TR | $4,666,000 | – | 55,000 | +100.0% | 0.83% | – |
| TEP | New | TALLGRASS ENERGY PARTNERS LP | $3,328,000 | – | 62,551 | +100.0% | 0.59% | – |
| VPU | New | VANGUARD WORLD FDSutilities etf | $2,838,000 | – | 25,200 | +100.0% | 0.50% | – |
| FTEC | New | FIDELITYmsci info tech i | $2,675,000 | – | 65,000 | +100.0% | 0.48% | – |
| TLT | New | ISHARES TR20 yr tr bd etf | $1,968,000 | – | 16,304 | +100.0% | 0.35% | – |
| FNCL | New | FIDELITYmsci finls idx | $1,895,000 | – | 53,900 | +100.0% | 0.34% | – |
| SDOG | New | ALPS ETF TRsectr div dogs | $877,000 | – | 20,416 | +100.0% | 0.16% | – |
| ENB | New | ENBRIDGE INC | $800,000 | – | 19,110 | +100.0% | 0.14% | – |
| TDIV | New | FIRST TR EXCHANGE TRADED FDnasd tech div | $778,000 | – | 24,545 | +100.0% | 0.14% | – |
| VDE | New | VANGUARD WORLD FDSenergy etf | $732,000 | – | 7,570 | +100.0% | 0.13% | – |
| ERX | New | DIREXION SHS ETF TRdly enrgy bull3x | $726,000 | – | 22,900 | +100.0% | 0.13% | – |
| FXU | New | FIRST TR EXCHANGE TRADED FDutilities alph | $611,000 | – | 22,301 | +100.0% | 0.11% | – |
| WELLPRI | New | WELLTOWER INC6.50% pfd prepet | $529,000 | – | 8,378 | +100.0% | 0.09% | – |
| FHLC | New | FIDELITYmsci hlth care i | $389,000 | – | 10,900 | +100.0% | 0.07% | – |
| FCHPRA | New | FELCOR LODGING TR INCpfd cv a $1.95 | $296,000 | – | 12,128 | +100.0% | 0.05% | – |
| EPRPRC | New | EPR PPTYSpfd c cnv 5.75% | $145,000 | – | 5,040 | +100.0% | 0.03% | – |
| VVC | New | VECTREN CORP | $129,000 | – | 2,200 | +100.0% | 0.02% | – |
| EPRPRE | New | EPR PPTYSconv pfd 9% sr e | $116,000 | – | 3,230 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
| INCYTE CORP | 31 | Q3 2023 | 2.1% |
| ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
| EXELIXIS INC | 31 | Q3 2023 | 1.8% |
| VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
| LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
| GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
| HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-07 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.